539 related articles for article (PubMed ID: 23271796)
1. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
[TBL] [Abstract][Full Text] [Related]
2. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular assist devices: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
[TBL] [Abstract][Full Text] [Related]
4. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time.
Dardas T; Mokadam NA; Pagani F; Aaronson K; Levy WC
J Am Coll Cardiol; 2012 Jul; 60(1):36-43. PubMed ID: 22541833
[TBL] [Abstract][Full Text] [Related]
5. Impact of using higher-risk donor hearts for candidates with pre-transplant mechanical circulatory support.
Han J; Moayedi Y; Yang W; Henricksen EJ; Lee R; Purewal S; Chang E; Duclos S; Lyapin A; Feng K; Hiesinger W; Teuteberg JJ; Khush KK
J Heart Lung Transplant; 2022 Feb; 41(2):237-243. PubMed ID: 34815161
[TBL] [Abstract][Full Text] [Related]
6. Regional differences in recipient waitlist time and pre- and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation algorithm.
Schulze PC; Kitada S; Clerkin K; Jin Z; Mancini DM
JACC Heart Fail; 2014 Apr; 2(2):166-77. PubMed ID: 24720925
[TBL] [Abstract][Full Text] [Related]
7. National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States.
Wever-Pinzon O; Naka Y; Garan AR; Takeda K; Pan S; Takayama H; Mancini DM; Colombo P; Topkara VK
J Heart Lung Transplant; 2016 Jul; 35(7):884-92. PubMed ID: 27151597
[TBL] [Abstract][Full Text] [Related]
8. Survival on the Heart Transplant Waiting List.
Bakhtiyar SS; Godfrey EL; Ahmed S; Lamba H; Morgan J; Loor G; Civitello A; Cheema FH; Etheridge WB; Goss J; Rana A
JAMA Cardiol; 2020 Nov; 5(11):1227-1235. PubMed ID: 32785619
[TBL] [Abstract][Full Text] [Related]
9. Impact of increased time at the highest urgency category on heart transplant outcomes for candidates with ventricular assist devices.
Colvin M; Miranda-Herrera D; Gustafson SK; Heubner B; Skeans M; Wang X; Snyder JJ; Kasiske BL; Israni AK
J Heart Lung Transplant; 2016 Mar; 35(3):326-334. PubMed ID: 26520245
[TBL] [Abstract][Full Text] [Related]
10. Temporary left ventricular assist devices as a bridge to heart transplantation.
Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
[TBL] [Abstract][Full Text] [Related]
11. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
[TBL] [Abstract][Full Text] [Related]
12. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
13. Pediatric heart transplant waiting list mortality in the era of ventricular assist devices.
Zafar F; Castleberry C; Khan MS; Mehta V; Bryant R; Lorts A; Wilmot I; Jefferies JL; Chin C; Morales DLS
J Heart Lung Transplant; 2015 Jan; 34(1):82-88. PubMed ID: 25447574
[TBL] [Abstract][Full Text] [Related]
14. Waitlist and transplant outcomes in heart transplant candidates bridged with temporary endovascular right ventricular assist devices.
Kwon JH; Skidmore SH; Bhandari K; Carnicelli AP; Yourshaw JP; Shorbaji K; Kilic A
J Heart Lung Transplant; 2024 Mar; 43(3):369-378. PubMed ID: 37951321
[TBL] [Abstract][Full Text] [Related]
15. Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing database.
Wozniak CJ; Stehlik J; Baird BC; McKellar SH; Song HK; Drakos SG; Selzman CH
Ann Thorac Surg; 2014 Apr; 97(4):1364-71; discussion 1371-2. PubMed ID: 24424016
[TBL] [Abstract][Full Text] [Related]
16. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.
Healy AH; Baird BC; Drakos SG; Stehlik J; Selzman CH
Ann Thorac Surg; 2013 Mar; 95(3):870-5. PubMed ID: 23218024
[TBL] [Abstract][Full Text] [Related]
17. Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation.
DeFilippis EM; Truby LK; Garan AR; Givens RC; Takeda K; Takayama H; Naka Y; Haythe JH; Farr MA; Topkara VK
JACC Heart Fail; 2019 Mar; 7(3):250-257. PubMed ID: 30819381
[TBL] [Abstract][Full Text] [Related]
18. Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes.
Truby LK; Garan AR; Givens RC; Takeda K; Takayama H; Trinh PN; Yuzefpolskaya M; Farr MA; Naka Y; Colombo PC; Topkara VK
Circ Heart Fail; 2018 Apr; 11(4):e004586. PubMed ID: 29666073
[TBL] [Abstract][Full Text] [Related]
19. Continuous flow left ventricular assist device technology has influenced wait times and affected donor allocation in cardiac transplantation.
Taghavi S; Jayarajan SN; Komaroff E; Mangi AA
J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1966-71, 1971.e1. PubMed ID: 24613158
[TBL] [Abstract][Full Text] [Related]
20. Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?
Morris AA; Chen C; Laskar SR; Smith AL; Vega JD
Int J Cardiol; 2019 Feb; 276():185-190. PubMed ID: 30482444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
